1 |
Walston, J., K. Silver, C. Bogardus, W. C. Knowler, F. S. Celi, S. Austin, B. Manning, A. D. Strosberg, M. P. Stern, N. Raben, J. D. Sorkin, J. Roth, and A. R. Shuldiner. 1995. Time of onset of non-insulin-dependent diabetes mellitus
and genetic variation in the beta3-adrenergic-receptor gene. N. Engl. J. Med. 333, 343-347
DOI
ScienceOn
|
2 |
Widen, E., M. Lehto, T. Kanninen, J. Walston, A. R. Shuldiner, and L. C. Groop. 1995. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333, 348-351
DOI
ScienceOn
|
3 |
Yoshida, T., N. Sakane, T. Umekawa, M. Sakai, T. Takahashi, and M. Kondo. 1995. Mutation of 3 adrenergic receptor gene and response to treatment of obesity. Lancet 1433-1434
|
4 |
Yuan, X., K. Yamada, K. Koyama, F. Ichikawa, S. Ishiyama, A. Koyanagi, W. Koyama, and K. Nonaka. 1997. Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res. Clin. Pract. 37, 1-7
DOI
ScienceOn
|
5 |
Perfetti, R., H. Hui, K. Chamie, S. Binder, M Seibert, J. McLenithan, K. Silver, and J. D. Walston. 2001. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J. Mol. Endocrinol. 27, 133-144
DOI
ScienceOn
|
6 |
Rissanen, J., J. Kuopusjarvi, J. Pihlajamaki, R. Sipilainen, S. Heikkinen, M. Vanhala, P. Kekalainen, J. Kuusisto, and M. Laakso. 1997. The Trp64Arg polymorphism of the beta3-Adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 20, 1319-1323
DOI
ScienceOn
|
7 |
Thomas, G. N., B. Tomlinson, J. C. N. Chan, R. P. Young, and J. A. J. H. Critchley. 2000. The Trp64Arg polymorphism of the β3-adrnergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int. J. Obes. 24, 545-551
DOI
ScienceOn
|
8 |
Rho, Y. H., S. J. Choi, Y. H. Lee, J. D. Ji, and G. G. Song. 2007. The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptor. Rheumatol. Int. 27, 835-839
DOI
ScienceOn
|
9 |
Shiwaku, K., A. Nogi, E. Anuurad, K. Kitajima, B. Enkhmaa, K. Shimono, and Y. Yamane. 2003. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int. J. Obes. Relat. Metab. Disord. 27, 1028-1036
DOI
ScienceOn
|
10 |
Tamaki, S., Y. Nakamura, Y. Tabara, T. Okamura, Y. Kita, T. Kadowaki, Y. Tsujita, M. Horie, T. Miki, and H. Ueshima. 2006. Relationship between metabolic syndrome and Trp64Arg polymorphism of the 3-adrenergic receptor gene ina general sample: the Shigaraki Study. Hypertens Res. 29, 891-896
DOI
ScienceOn
|
11 |
Urhammer, S. A., J. O. Clausen, T. Hansen, and O. Pedersen. 1996. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene. Diabetes 45,
1115-1120
DOI
ScienceOn
|
12 |
Kissebah, A. H., G. E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, R. G. James, J. A. Marks, G. R. Krakower, H. J. Jacob, J. Weber, L. Martin, J. Blangero, and A. G. Comuzzie. 2000. Quantitative trait loci on chromosomes
3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. 97, 14478-14483
DOI
ScienceOn
|
13 |
Lehman, D. M., J. Hamlington, K. J. Hunt, R. J. Leach, R. Arya, H. Abboud, R. Duggirala, J. Blangero, H. H. Goring, and M. P. Stern. 2006. A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family. Diabetes Metab. Res. Rev. 22, 331-336
DOI
ScienceOn
|
14 |
Matsushita, Y., T. Yokoyama, N. Yoshiike, Y. Matsumura, C. Date, K. Kawahara, and H. Tanaka. 2003. The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with body weight or body mass index in Japanese: A longitudinal analysis. J. Clin. Endocrinol. Metab. 88, 5914-5920
DOI
ScienceOn
|
15 |
Li, L. S., F. Lonnqvist, H. Luthman, and P. Arner. 1996. Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39, 857-860
|
16 |
Lowell, B. B., V. S. Susulic, A. Hamann, J. A. Lawitts, J. Himms-Hagen, B. B. Boyer, L. P. Kozak, and J. S. Flier. 1993. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740-742
DOI
ScienceOn
|
17 |
Masuo, K., T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck. 2005. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 28, 3429-3434
|
18 |
Miyaki, K., S. Sutani, H. Kikuchi, I. Takei, M. Murata, K. Watanabe, and K. Omae. 2005. Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the 3-adrenergic receptor gene in healthy Japanese men. J. Epidemiol. 15, 203-210
DOI
ScienceOn
|
19 |
Dunajska, K., F. Lwow, A. Milewicz, D. Jedrzejuk, L. Laczmanski, K. Belowska-Bien, J. Urban, and A. Szuba. 2008. beta(3)-adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women. Gynecol. Endocrinol. 24, 133-138
DOI
ScienceOn
|
20 |
Emorine, L. J., S. Marullo, M. M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko, and A. D. Strosberg. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science 245, 1118-1121
DOI
|
21 |
Hedrick, P. W. 1987. Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341
|
22 |
Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502
|
23 |
Garcia-Rubi, E. and J. Calles-Escandon. 1999. Insulin resistance and type 2 diabetes mellitus: its relationship with the beta 3-adrenergic receptor. Arch. Med. Res. 30, 459-464
DOI
ScienceOn
|
24 |
Hamann, A., H. Benecke, Y. Le Marchand-Brustel, V. S. Susulic, B. B. Lowell, and J. S. Flier. 1995. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44, 1266-12738
DOI
ScienceOn
|
25 |
Hegele, R. A., S. Harris, A. J. G. Hanley, H. Azouz, P. W. Connelly, and B. Zimman. Absence of association between genetic variation of the 3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 21, 851-854
DOI
ScienceOn
|
26 |
Kadowaki, H., K. Yasuda, K. Iwamoto, S. Otabe, K. Shimokawa, K. Silver, J. Walston, H. Yoshinaga, K. Kosaka, N. Yamada, Y. Saito, R. Hagura, Y. Akanuma, A. Shuldiner, Y. Yazaki, and T. Kadowaki. 1995. A mutation in the beta
3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215, 555-560
DOI
ScienceOn
|
27 |
Chamberlain, P. D., K. H. Jennings, F. Paul, J. Cordell, A. Berry, S. D. Holmes, J. Park, J. Chambers, M. V. Sennitt, M. J. Stock, M. A. Cawthorne, P. W. Young, and G. J. Murphy. 1999. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int. J. Obes. Relat. Metab. Disord. 23, 1057-1065
DOI
ScienceOn
|
28 |
Clement, K., C. Vaisse, B. S. Manning, A. Basdevant, B. Guy-Grand, J. Ruiz, K. D. Silver, A. R. Shuldiner, P. Froguel, and A. D. Strosberg. 1995. Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333, 352-354
DOI
ScienceOn
|
29 |
Don, R. H., P. T. Cox, B. J. Wainwright, K. Baker, and J. S. Mattick. 1991. Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19, 4008
DOI
ScienceOn
|